A citation-based method for searching scientific literature

Cecilia L Speyer, Ali H Hachem, Ali A Assi, Jennifer S Johnson, John A DeVries, David H Gorski. PLoS One 2014
Times Cited: 39



Chi Zhang, Xian-rui Yuan, Hao-yu Li, Zi-jin Zhao, Yi-wei Liao, Xiang-yu Wang, Jun Su, Shu-shan Sang, Qing Liu. Cell Physiol Biochem 2015
Times Cited: 52




List of shared articles



Times cited

Novel thienopyrimidine analogues as potential metabotropic glutamate receptors inhibitors and anticancer activity: Synthesis, In-vitro, In-silico, and SAR approaches.
Mohammed A Khedr, Khadiga M Abu-Zied, Wafaa A Zaghary, Ahmed S Aly, Dina N Shouman, Hesham Haffez. Bioorg Chem 2021
5

Metabotropic glutamate receptors in cancer.
Lumeng J Yu, Brian A Wall, Janet Wangari-Talbot, Suzie Chen. Neuropharmacology 2017
57

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression.
Kevinn Eddy, Mohamad Naser Eddin, Anna Fateeva, Stefano Vito Boccadamo Pompili, Raj Shah, Saurav Doshi, Suzie Chen. Cells 2022
3

Targeting metabotropic glutamate receptors in the treatment of primary brain tumors.
Luisa Iacovelli, Rosamaria Orlando, Alessandro Rossi, Paola Spinsanti, Daniela Melchiorri, Ferdinando Nicoletti. Curr Opin Pharmacol 2018
3

The current management of brain metastasis in melanoma: a focus on riluzole.
Lumeng J Yu, Brian A Wall, Suzie Chen. Expert Rev Neurother 2015
9

Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions.
Hamid Mollazadeh, Elmira Mohtashami, Seyed H Mousavi, Mohammad Soukhtanloo, Mohammad M Vahedi, Azar Hosseini, Amir R Afshari, Amirhossein Sahebkar. Curr Pharm Des 2020
8

Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent.
Qifu Xu, Chunxi Liu, Jie Zang, Shuai Gao, C James Chou, Yingjie Zhang. Front Cell Dev Biol 2020
5

2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents.
Yichao Wan, Jiabing Long, Han Gao, Zilong Tang. Eur J Med Chem 2021
11

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer.
Anna E M Bastiaansen, A Mieke Timmermans, Marcel Smid, Carolien H M van Deurzen, Esther S P Hulsenboom, Wendy J C Prager-van der Smissen, Renée Foekens, Anita M A C Trapman-Jansen, Peter A E Sillevis Smitt, Theo M Luider,[...]. Sci Rep 2020
5

Glutamatergic Signaling a Therapeutic Vulnerability in Melanoma.
Kevinn Eddy, Suzie Chen. Cancers (Basel) 2021
3

Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas.
Mery Stefani Leivas Pereira, Fábio Klamt, Chairini Cássia Thomé, Paulo Valdeci Worm, Diogo Losch de Oliveira. Oncotarget 2017
31